Followers | 777 |
Posts | 81244 |
Boards Moderated | 9 |
Alias Born | 12/25/2009 |
Wednesday, February 14, 2018 3:55:03 PM
https://backend.otcmarkets.com/otcapi/company/sec-filings/12538307/content/html
Mark Lucky is a hands-on executive with extensive senior finance and general management experience with rapidly growing technology companies, assisting in areas of operational, financial and strategic planning, procurement of equity and debt growth capital, legal and regulatory compliance, risk management, and human resource management. He has been a public company CFO for 10+ years, with a focus on improving operations, profitability, cash flow, and the balance sheet.
Expertise & Management Skills
• SEC and Financial Reporting (10-K, 10-Q, S-1, etc.)
• Strategic Planning & Implementation
• Budget Development & Management - Financial Planning and Analysis
• Contract Negotiations / M&A Integration
• Key Performance Indicator Development
He has extensive merger and acquisition experience, with over ten closed transactions in the last decade.
Specialties:
SEC
Financial Planning and Analysis
Mergers & Acquisitions
Finance
Board of Director
Recent VISM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 09:16:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 09:20:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:22:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 01:28:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:41:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 08:33:23 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM